Regional flights up 9pc
PASSENGERS flying with Aer Lingus Regional jumped by 9pc in March in comparison the the same month in 2012, the airline has said, a ninth consecutive month of growth.
Chief commercial officer of Aer Lingus Regional operator Stobart, Simon Fagan, said new Cork-Newcastle and Shannon-Bristol services had boosted business, as well as routes that connect people from Newcastle and Glasgow to Aer Lingus transatlantic flights leaving from Shannon.
BARBIE LOSING APPEAL
MATTEL, the world's largest toymaker, has reported a net loss for the January to April period due to a fall in sales of its iconic Barbie dolls and Fisher-Price toys for preschoolers.
The company reported a net loss of $11.2m (€8m) for the quarter compared with a net income of $38.5m a year earlier. Mattel is shifting focus to the fast-growing market for building block toys to boost sales. But investors aren't convinced and its stock has fallen about 20pc this year.
MULBERRY SCRAPS HIKES
LUXURY brand Mulberry is to scrap its strategy of hiking prices after the move away from more affordable handbags resulted in its second profit warning in three months.
Effectively lowering its outlook for the years ending March 2014 and 2015, Mulberry said its decision to reverse the strategy of higher prices brought in by ousted chief executive Bruno Guillon would have a short-term impact on profit.
PEPSI SNACKS ADD FIZZ
PEPSI has reported a higher quarterly profit, lifted by sales gains in its snacks business. The maker of Pepsi-Cola and Tropicana juice said that excluding the impact of currency translation and changes to PepsiCo's business, revenues for the three months ending March 22 rose 4pc.
But one weak spot for the company was soda sales. In North America, its soft drink volume fell 1pc.
GSK HAVING A CHECK-UP
DRUGMAKER GlaxoSmithKline (GSK) – hit by bribery claims in five countries – is to employ hundreds more doctors as members of staff as it seeks to build a new sales model designed to eliminate sharp marketing practices.
Following a decision to cut commercial ties with outside doctors, GSK expects to increase its in-house team of physicians by 10-20pc over the next year or so from around 1,500 at present, chief medical officer James Shannon said.